TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03321851

Intervention type: DEVICE
Group type: OTHER
Intervention: V-sensor device user
Description: Participants use device to detect the 5 vital signs (Blood Pressure, Pulse, Respiration, SpO2, Temperature).
Study: NCT01168466

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: QEEG-based Neurofeedback Training
Description: EEG amplitude is measured and visual and auditory rewards are given when amplitude at specific locations is modified to meet preset threshholds.
Study: NCT04258644

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab+Apatinib+Paclitaxel-albumin+S-1
Description: Combination therapy of 4 drugs, 21 days for one cycle.
Study: NCT01309360

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: midazolam
Description: Prior to performing the regional anesthesia the investigators administered midazolam as a premedication by mouth (3,75-7,5mg) or intravenously (2-3mg).
Study: NCT01970826

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single Dental Implants
Description: place single unit dental implants, 2 mm below crestal bone and follow manufacturer guidelines.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single Dental Implants
Description: place single unit dental implants, 2 mm below crestal bone and follow manufacturer guidelines.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sterilized Aseptic
Description: Operatory room will be prepared totally aseptic

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sterilized Aseptic
Description: Operatory room will be prepared totally aseptic

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sterilized Aseptic
Description: Operatory room will be prepared totally aseptic

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sterilized Clean
Description: Operatory room will be prepared clean but not aseptic

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sterilized Clean
Description: Operatory room will be prepared clean but not aseptic

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sterilized Clean
Description: Operatory room will be prepared clean but not aseptic
Study: NCT01309360

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: midazolam
Description: Prior to performing the regional anesthesia the investigators administered midazolam as a premedication by mouth (3,75-7,5mg) or intravenously (2-3mg).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: midazolam
Description: Prior to performing the regional anesthesia the investigators administered midazolam as a premedication by mouth (3,75-7,5mg) or intravenously (2-3mg).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: prilocaine 1%
Description: 40 outpatients : 40ml prilocaine 1% were administered for axillary plexus block

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: prilocaine 1%
Description: 40 outpatients : 30ml prilocaine 1% were administered for axillary plexus block

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: prilocaine 1%
Description: 40 outpatients : 20ml prilocaine 1% were administered for axillary plexus block
Study: NCT01970826

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Full-Mouth Dental Implants
Description: dental implants for full-mouth implant rehabilitation.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Full-Mouth Dental Implants
Description: dental implants for full-mouth implant rehabilitation.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Partial Rehabilitation
Description: two or more implants to support partial rehabilitation

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Partial Rehabilitation
Description: two or more implants to support partial rehabilitation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Duration of Surgery
Description: it will be measure the amount of time to perform the dental implant surgery. It will be measured from the time that the surgeon does the first incision until the last suture is made.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Duration of Surgery
Description: it will be measure the amount of time to perform the dental implant surgery. It will be measured from the time that the surgeon does the first incision until the last suture is made.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Duration of Surgery
Description: it will be measure the amount of time to perform the dental implant surgery. It will be measured from the time that the surgeon does the first incision until the last suture is made.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Duration of Surgery
Description: it will be measure the amount of time to perform the dental implant surgery. It will be measured from the time that the surgeon does the first incision until the last suture is made.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Duration of Surgery
Description: it will be measure the amount of time to perform the dental implant surgery. It will be measured from the time that the surgeon does the first incision until the last suture is made.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Duration of Surgery
Description: it will be measure the amount of time to perform the dental implant surgery. It will be measured from the time that the surgeon does the first incision until the last suture is made.
Study: NCT02157805

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: beef meat
Description: Meat cooking conditions~1. st condition : beef meat cooked during 5 minutes at 55°C~2. nd condition : beef meat cooked during 30 minutes à 90°C

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: beef meat
Description: Meat cooking conditions~1. st condition : beef meat cooked during 5 minutes at 55°C~2. nd condition : beef meat cooked during 30 minutes à 90°C
Study: NCT02464189

Intervention type: OTHER
Intervention: Q-Kap
Study: NCT04337814

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EMLA Cream
Description: Topical anaesthetic cream

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: Oral analgesic syrup (non-steroidal anti inflammatory drug)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: Oral analgesic syrup (non-steroidal anti inflammatory drug)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo syrup
Description: Placebo syrup similar to Ibuprofen
Study: NCT03297645

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: School
Description: CHWs will ensure that families submit required health paperwork (e.g., asthma action plan, medication release form) and confirm with school nurses that children have the appropriate medications. School nurses will be given a standardized protocol to follow with clear guidelines for caring for students with asthma. The CHW assigned to the family will work with the school nurse to ensure that communication with the medical provider is occurring.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Asthma education
Description: CHWs will deliver evidence-based asthma education to parents and children. Content is drawn from existing asthma management programs, and adapted for families in Richmond. Between sessions, CHWs will call parents at least monthly to check in and assess family asthma management, including healthcare utilization since the last contact.
Study: NCT04337814

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo cream
Description: Placebo cream similar to EMLA

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo cream
Description: Placebo cream similar to EMLA
Study: NCT00506064

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: 0.15 mg/kg by mouth (PO) Daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two, three, or four starch tablet or capsules before bed

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: Sleep study surveys, two per day completed each evening, lasting 10 minutes

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Questionnaire
Description: Sleep study surveys, two per day completed each evening, lasting 10 minutes
Study: NCT03535935

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Astragalus Powder
Description: 3 grams of water soluble astragalus sachets (equivalent to 15g raw herbs) administrated orally on top of standard medical care for 48 weeks.~Patients will have 5 days of medicine per week and will be advised to take the medicine once daily dissolved in boiling water in the first 5 days of the week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine medical care (active comparator)
Description: Angiotensin converting enzyme inhibitor or angiotensin receptor blocker

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine medical care (active comparator)
Description: Angiotensin converting enzyme inhibitor or angiotensin receptor blocker
Study: NCT03355326

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glycerin Suppository
Description: Glycerin suppository is given once daily beginning after conditions described are met and continued until discontinue conditions are met.
Study: NCT04575636

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Magnetic Resonance Lymphography
Description: Magnetic Resonance Lymphography using Siemens 3T MRI unit and Gadobutrol as a contrast agent to visualize the lymphatic system

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Magnetic Resonance Lymphography
Description: Magnetic Resonance Lymphography using Siemens 3T MRI unit and Gadobutrol as a contrast agent to visualize the lymphatic system
Study: NCT02271958

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mifepristone

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mifepristone

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mifepristone

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PLACEBO
Study: NCT03297645

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Asthma education
Description: CHWs will deliver evidence-based asthma education to parents and children. Content is drawn from existing asthma management programs, and adapted for families in Richmond. Between sessions, CHWs will call parents at least monthly to check in and assess family asthma management, including healthcare utilization since the last contact.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home environmental remediation
Description: Healthy Homes will complete home-based environmental assessments using evidence-based protocols. Healthy Homes will provide real-time education and share information about their findings and recommendations for action. Families are provided with low-cost intervention materials (e.g., filters, pillow covers), as well as behavioral modifications to aid in the reduction of asthma triggers in the home.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home environmental remediation
Description: Healthy Homes will complete home-based environmental assessments using evidence-based protocols. Healthy Homes will provide real-time education and share information about their findings and recommendations for action. Families are provided with low-cost intervention materials (e.g., filters, pillow covers), as well as behavioral modifications to aid in the reduction of asthma triggers in the home.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Informational mail
Description: Family will be mailed publicly available asthma information every 3 months.
Study: NCT00818753

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dabigatran 110 mg
Description: comparison of different dabigatran dosages with unfractionated heparin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dabigatran 150 mg
Description: comparison of different dabigatran dosages with unfractionated heparin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: unfractionated heparin
Description: comparison of different dosages dabigatran with unfractionated heparin
Study: NCT02186860

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR-T cells
Description: Given IV
Study: NCT03710915

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HG146
Description: HG146 will be administered every other day for 14 days, followed by 1 week off the drug with each treatment cycle of 21-days.
Study: NCT04080622

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Selenium
Description: Selenium 300 µg/day (IV infusion)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: NaCl 0,9% (IV infusion)
Study: NCT03647358

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PET/CT Scan
Description: Up to four whole-body PET scans (approximately 24, 48, and 120 hours post 124I oral dose) will be performed on one of the GE Discovery 710 or 690 PET scanners.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iodine-124
Description: Patients will receive 0.9 mg injections of rhTSH on two consecutive days. Twenty-four hours after the last injection of rhTSH each patient will receive approximately 5 mCi (range: 4-7 mCi) of 124I orally as a single dose.
Study: NCT01155180

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leptin
Description: Hormone - daily self injections for 6 months

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT01007721

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluticasonepropionate nasal spray 200 mcg
Description: Fluticasonepropionate nasal spray 200 mcg (qd, 2 puffs of 50 mcg per nostril)
Study: NCT03042559

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Protonics Knee brace
Description: The Protonics system has been introduced to physical therapists as a potential treatment for PFPS. The system includes a brace set to resist knee flexion and a set of specific exercises to perform daily. Through resistance to knee flexion, the system is advertised to decrease retropatellar contact pressure due to changes in pelvis inclination and available hip rotation. Specifically, resistance to knee flexion is purported to increase hamstring activity and inhibit the activity of the tensor fasciae latae and psoas muscles. The manufacturer asserts that prolonged use of the system results in greater hamstring activation, which leads to permanent structural changes through reciprocal inhibition at the hip and pelvis. The warm-up consisted of the subject wearing the ProtonicsTM knee brace set at a moderate resistance level and flexing the knees while sitting, standing, and reclining in the supine and prone positions.
Study: NCT03915782

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Description: Remote ischemic conditioning (RIC): Four cycles of \[5 minutes of brachial cuff inflation at 200 millimeters (mm) of mercury (Hg) followed by 5 minutes of cuff deflation\] started as soon as possible after Magnetic Resonance Imaging (MRI).

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Patients with a sham procedure of remote ischemic conditioning
Description: Sham procedure: Four cycles of \[5 minutes of brachial cuff inflation at 30 millimeters (mm) of mercury (Hg) followed by 5 minutes of cuff deflation\] started as soon as possible after Magnetic Resonance Imaging (MRI).
Study: NCT05878197

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Straw phonation
Description: The two experimental groups will receive either straw phonation therapy or resonant voice therapy. The hierarchical structure of the therapy sessions will be equal for the three programs. In each session, vocal rest pauses will be foreseen by playing games, performing drawing assignments, etc. This will make the therapy more pleasant and less intensive. All voice therapy programs will be guided by the same experienced voice therapist.~Content:~Day 1: counseling (anatomy and physiology of the voice and vocal fold nodules), vocal hygiene recommendations (water intake, avoiding vocal misuse and abuse) Day 2: breathing exercises, vocal hygiene recommendations, straw phonation on vowel and syllable level, pitch variations Day 3: breathing exercises, vocal hygiene recommendations, straw phonation on word and sentence level, pitch variations Day 4: straw phonation in spontaneous speech, combination exercises

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resonant voice therapy
Description: The two experimental groups will receive either straw phonation therapy or resonant voice therapy. The hierarchical structure of the therapy sessions will be equal for the three programs. In each session, vocal rest pauses will be foreseen by playing games, performing drawing assignments, etc. This will make the therapy more pleasant and less intensive. All voice therapy programs will be guided by the same experienced voice therapist.~Content:~Day 1: counseling (anatomy and physiology of the voice and vocal fold nodules), vocal hygiene recommendations (water intake, avoiding vocal misuse and abuse) Day 2: breathing exercises, vocal hygiene recommendations, resonant voice therapy on vowel and syllable level, pitch variations Day 3: breathing exercises, vocal hygiene recommendations, resonant voice therapy on word and sentence level, pitch variations Day 4: resonant voice therapy in spontaneous speech, combination exercises

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Vocal Hygiene
Description: Participants of the control group will receive a sham treatment, including the exact same games, drawing assignments, etc. as in the experimental groups. However, no SOVT or other active vocal techniques will be practiced. Vocal hygiene guidelines (e.g. avoid screaming, imitating voices, sufficient hydration etc.) will be kept equally in the four groups. All voice therapy programs will be guided by the same experienced voice therapist.~Content:~Day 1: counseling (anatomy and physiology of the voice and vocal fold nodules), vocal hygiene recommendations (water intake, avoiding vocal misuse and abuse) Day 2: breathing exercises, vocal hygiene recommendations Day 3: breathing exercises, vocal hygiene recommendations Day 4: combination exercises
Study: NCT03042559

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sports Cords
Description: Subjects assigned to the sport cord group were asked to do the same warm-ups and exercises using the sport cord in the supine, standing, sitting, and prone positions. prone. The only difference is that subjects were asked to only walk backwards instead of forwards in order to avoid activation of the hip flexor muscle. The appropriate level of resistance for each subject was calculated by multiplying their weight in pounds by 0.3. Subjects were then given either light, medium, or heavy resistance cords according to the following classification scheme: light (pink color) with resistance 3 (R3), 0-30 lbs.; medium (orange color) with resistance 5 (R5) 0-50 lbs.; heavy (yellow color) with resistance 7 (R7) 0-70 lbs. All subjects completed three study visits, and a total of four measurements were taken at baseline, immediately following the first session, at two weeks, and at 4 weeks.
Study: NCT03520322

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mastoid Oscillator
Description: The oscillator will be placed over the mastoid of their involved ear and secured via an elastic/Velcro headband. The subject is positioned so as to place the endolymphatic duct into a gravitationally dependent orientation (the subject lying on their contralateral side with the face slightly tilted towards the floor). The device is turned on and operated for 30 minutes.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Control Device
Description: The control device will be placed over the mastoid of their involved ear and secured via an elastic/Velcro headband. The subject is positioned so as to place the endolymphatic duct into a gravitationally dependent orientation (the subject lying on their contralateral side with the face slightly tilted towards the floor). The device is turned on and operated for 30 minutes.
Study: NCT00561392

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivastigmine 5 and 10 cm^2 patch
Study: NCT03963232

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Galcanezumab
Description: Administered SC

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study: NCT04080245

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Treatment Group Live Attenuated Flu Vaccine (LAIV)
Description: We will administer LAIV once as a vaccine prime and IIV once as a vaccine boost with serial weekly blood draws for a month to validate a biomarker of LAIV efficacy.
Study: NCT04866758

Intervention type: OTHER
Intervention: Survey
Description: All data gathered will be quantitative in nature. In addition to participant completed surveys, additional demographic, and diagnosis/treatment related information will be collected from the patient's electronic medical record via Health Data Compass. Subsequent data collected as part of the patient's standard psychosocial and cancer related care (i.e., health outcomes, future utilization of UCCC psychosocial services) will also be gathered. This subsequent data collection will not include further participation, but continued access to the patient's medical record. Protected health information collected for this project will include dates (e.g., birth dates, date of diagnosis, date since last treatment, death dates) and participant zip codes. No other identifiable data will be collected. A separate survey emailed to the participant at the end of the study will collect information regarding the participant's completion status of the survey.
Study: NCT01905917

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation
Study: NCT03178188

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsed-dye Laser
Description: 595 nm Pulsed-dye Laser; 7mm spot sizes, 6msec pulse durations, 8j/cm2 fluences, dynamic cooling device 30/20, 4 sessions with 4 weeks interval

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Cryogen spray with the setting of dynamic cooling device 30/20